m 16209 has been researched along with benzofurans in 10 studies
| Studies (m 16209) | Trials (m 16209) | Recent Studies (post-2010) (m 16209) | Studies (benzofurans) | Trials (benzofurans) | Recent Studies (post-2010) (benzofurans) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 13,293 | 451 | 4,970 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, K; Miwa, I; Mizota, M; Murakami, K; Murakami, N; Nakayama, K; Ohta, M; Okuda, J | 2 |
| Kato, K; Miwa, I; Mizota, M; Nakayama, K; Okuda, J | 1 |
| Ida, K; Kato, K; Miwa, I; Mizota, M; Murakami, N; Nakayama, K; Ohta, M; Okuda, J | 1 |
| Kato, K; Miwa, I; Mizota, M; Murakami, N; Nakayama, K; Notsu, T; Ohta, M; Okuda, J | 1 |
| Imura, H; Kato, K; Kuzuya, H; Miwa, I; Mizota, M; Murakami, N; Nakao, K; Ohta, M; Okuda, J; Yoshimasa, Y | 1 |
| Hashimoto, K; Kato, K; Miwa, I; Mizota, M; Murakami, N; Ohta, M; Okuda, J | 1 |
| Hashimoto, K; Imura, H; Inoue, G; Kato, K; Kuzuya, H; Miwa, I; Mizota, M; Murakami, N; Nakao, K; Ohta, M; Okuda, J | 1 |
| Hayashi, T; Inoue, G; Kato, K; Kohno, S; Kuzuya, H; Murakami, N; Nakao, K; Okamoto, M; Yoshimasa, Y | 1 |
| Kato, K; Miwa, I; Mizota, M; Murakami, N; Nakayama, K; Ohta, M; Okuda, J | 1 |
10 other study(ies) available for m 16209 and benzofurans
| Article | Year |
|---|---|
Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats.
Topics: Aldehyde Reductase; Animals; Benzofurans; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Hydantoins; Inositol; Male; Motor Neurons; Neural Conduction; Polymers; Rats; Rats, Inbred Strains; Streptozocin | 1991 |
Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
Topics: Aldehyde Reductase; Animals; Benzofurans; Cataract; Cattle; Diabetic Neuropathies; Hydantoins; Imidazoles; Imidazolidines; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Rhodanine; Sorbitol; Thiazolidines | 1991 |
Effects of novel hydantoin derivatives with aldose reductase inhibiting activity on galactose-induced cataract in rats.
Topics: Aldehyde Reductase; Animals; Benzofurans; Cataract; Cattle; Enzyme Inhibitors; Galactose; Hydantoins; Lens, Crystalline; Male; Rats; Rats, Inbred Strains | 1990 |
Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats.
Topics: Aldehyde Reductase; Animals; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hydantoins; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Rats; Rats, Wistar; Streptozocin | 1995 |
Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats.
Topics: Aldehyde Reductase; Animals; Benzofurans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hydantoins; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Pancreas; Perfusion; Potassium Channels; Rats; Rats, Wistar; Streptozocin | 1995 |
Effects of M16209, a new antihyperglycemic agent, on insulin sensitivity in vivo: euglycemic clamp studies in rats.
Topics: Adult; Animals; Benzofurans; Glucose Clamp Technique; Humans; Hydantoins; Hyperinsulinism; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rats; Rats, Wistar | 1996 |
Acceleration of glycolysis in erythrocytes by the antidiabetic agent M16209.
Topics: Aldehyde Reductase; Animals; Benzofurans; Erythrocytes; Glucose; Glyceraldehyde; Glycolysis; Humans; Hydantoins; Hypoglycemic Agents; Imidazoles; Imidazolidines; In Vitro Techniques; Lactic Acid; Male; Phosphofructokinase-1; Rats; Rats, Wistar; Tolbutamide | 1996 |
Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent.
Topics: Administration, Oral; Animals; Benzofurans; Blood Glucose; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hydantoins; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Rats; Rats, Zucker | 1996 |
Antihyperglycemic mechanism of M16209, an antidiabetic agent, in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Benzofurans; Biological Transport; CHO Cells; Cricetinae; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Hydantoins; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Macromolecular Substances; Mice; Monosaccharide Transport Proteins; Muscle Proteins; Phosphoproteins; Phosphorylation; Receptor, Insulin; Signal Transduction; Tyrosine | 1997 |
Effects of 1-(3-bromobenzofuran-2-ylsulfonyl)hydantoin on human aldose reductase examined by a new application of HPLC system for measuring tissue polyol.
Topics: Aldehyde Reductase; Animals; Benzofurans; Chromatography, High Pressure Liquid; Electrochemistry; Enzyme Inhibitors; Galactitol; Humans; Hydantoins; In Vitro Techniques; Kinetics; Male; Polymers; Rabbits; Recombinant Proteins | 1997 |